Loading...
Market
What will be the reported effectiveness of Oxford University's Marburg virus vaccine by December 31, 2024?
2
Resolution / Starting Odds
Less than 50% • 25%
50% to 70% • 25%
70% to 90% • 25%
More than 90% • 25%
Peer-reviewed scientific journals or official announcements from Oxford University
Story
Oxford University Begins Human Testing of Marburg Virus Vaccine on July 12: BBC
Jul 12, 2024, 05:04 AM
Scientists at Oxford University have commenced human testing of a vaccine for the Marburg virus on July 12. This development, reported by BBC, marks a significant step in combating the deadly virus, which has been a concern for global health authorities due to its high mortality rate and potential for outbreaks. The Marburg virus is related to the Ebola virus and causes severe hemorrhagic fever in humans. The vaccine aims to provide immunity and prevent future outbreaks, contributing to global health security.
View original story
Similar markets
Successful • 25%
Partially Successful • 25%
Unsuccessful • 25%
No Results Released • 25%
Successful containment • 25%
Partial containment • 25%
No containment • 25%
Worsening outbreak • 25%
Highly effective • 25%
Moderately effective • 25%
Slightly effective • 25%
Ineffective • 25%
Yes • 50%
No • 50%
None reported • 25%
Few minor events • 25%
Significant events • 25%
Major public health concern • 25%
Under 50% • 25%
50% to 69% • 25%
70% to 88% • 25%
Over 88% • 25%
Effective • 25%
Moderately Effective • 25%
Ineffective • 25%
Halted • 25%
Yes • 50%
No • 50%
Positive • 25%
Negative • 25%
Mixed • 25%
Not published • 25%